Descriptive epidemiology of skin cancer incidence and mortality

Skin Cancer Prevention

Volumn , Issue , 2016, Pages 203-223

  Boniol, Mathieu ^a   Dore, Jean Francois ^a   Autier, Philippe ^a   Smans, Michel ^a   Boyle, Peter ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35948992450     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. Urteaga OB, Pack GT. On the antiquity of melanoma. Cancer 1966; 19(5):607-610.
2. Laennec RTH. Sur les melanoses. Bulletin de la Faculté; de Médecine de Paris 1806. Premier serie 1804-1808 (Tome premier):2-22.
3. Carswell R. Illustrations of the elementary forms of disease. Londres: Longman, Orme, Brown, Green and Longman, 1838.
4. Norris W. Eight cases of melanosis with pathological and therapeutical remarks on that disease. Londres: Longman, Brown, Green, Longman and Roberts, 1857.
5. Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1975-2000, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2000, 2003.
6. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0, Lyon: IARC Press, 2004.
7. Nguyen HL, Armstrong BK, Coates M. Cutaneous melanoma in NSW in 1983 to 1995. New South Wales: Sydney Cancer Council, 1997.
8. Lee JA, Scotto J. Melanoma: linked temporal and latitude changes in the United States. Cancer Causes Control 1993; 4(5):413-418.
9. Eklund G, Malec E. Sunlight and incidence of cutaneous malignant melanoma. Effect of latitude and domicile in Sweden. Scand J Plast Reconstr Surg 1978; 12(3):231-241.
10. Magnus K. The Nordic profile of skin cancer incidence. A comparative epidemiological study of three main types of skin cancer. Int J Cancer 1991; 47:12-19.
11. De Vries E, Boniol M, Dore JF, Coebergh JWW for the EUROCARE working group. Lower incidences rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. Eur J Cancer 2004; 40(7):1045-1052.
12. Scotto J, Nam JM. Skin melanoma and seasonal patterns. Am J Epidemiol 1980; 111(3):309-314.
13. Holman CDJ, Armstrong BK. Skin melanoma and seasonal patterns. Am J Epidemiol 1981; 113:202.
14. Poldenak AP. Seasonal patterns in the diagnosis of malignant melanoma of skin and eye in upstate New York. Cancer 1984; 54(11):2587-2594.
15. Swerdlow AJ. Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford region. Br J Cancer 1985; 52(6):893-900.
16. Schwartz SM, Armstrong BK, Weiss NS. Seasonal variation in the incidence of cutaneous malignant melanoma: an analysis by body site and histologic type. Am J Epidemiol 1987; 126(1):104-111.
17. Akslen LA, Hartweit F. Cutaneous melanoma-season and invasion? A preliminary report. Acta Derm Venereol 1988; 68(5):390-394.
18. Braun M, Tucker A, Devesa S, Hoover R. Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma. Melanoma Res 1994; 4:235-241.
19. Akslen LA. Seasonal variation in melanoma progress. J Natl Cancer Inst 1995; 87(13):1025-1026.
20. Blum A, Ellwanger U, Garbe C. Seasonal patterns in the diagnosis of cutaneous malignant melanoma: analysis of the data of the German Central Malignant Melanoma Registry. Br J Dermatol 1997; 136(6):968-969.
21. Lambe M, Blomqvist P, Bellocco R. Seasonal variation on the diagnosis of cancer: a study based on national cancer registration in Sweden. Brit J Cancer 2003; 88: 1358-1360.
22. Azizi E, Schaaf A, Lazarov A, et al. Decreased density of epidermal dendritic cells in melanocytic naevi: the possible role of in vivo sun exposure. Melanoma Res 1999; 9(5):521-527.
23. Stanganelli L, Bauer P, Bucchi L, et al. Critical effects of intense sun exposure on the expression of epiluminescence microscopy features of acquired melanocytic nevi. Arch Dermatol 1997; 133:979-982.
24. Hinds MW, Lee J, Kolonel LN. Seasonal patterns of skin melanoma incidence in Hawai. Am J Public Health 1981; 71:496-499.
25. Boniol M, De Vries E, Coebergh JW, Dore JF. EUROCARE Working Group. Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analysis using the EUROCARE group of registries. Eur J Cancer 2005; 41(1):126-132.
26. Facts and figures 1997. Atlanta: American Cancer Society, 1997.
27. Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003; 51(1 Pt 1): 3-30.
28. Van der Esch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma is unlikely. Int J Cancer 1991; 47:483-489.
29. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89(6):1269-1278.
30. Lipsker DM, Hedelin G, Heid E, et al. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 1999; 135(12): 1451-1456.
31. Lee JA. The systematic relationship between melanomas diagnosed in situ and when invasive. Melanoma Res 2001; 11:523-529.
32. Bulliard JL, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control 1999; 10(5):407-416.
33. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 2001; 92(3):457-462.
34. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93(9):678-683.
35. Cooper S. First lines of theory and practice of surgery. London: Longman, Orme, Brown, Green and Longman, 1840.
36. Farrell HJ. Cutaneous melanomas with special reference to prognosis. Arch Dermatol Syph 1932; 26:110-124.
37. Davis NC, Shaw HM, McCarthy WH. Melanoma: an historical perspective. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London: Martin Dunitz, 2004:1-12.
38. Keefe M, Mackie RM. The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group. Br J Cancer 1991; 64(3):598-602.
39. Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997; 15(3):1039-1051.
40. Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst 2000; 92(10):811-818.
41. De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003; 107(1):119-126.
42. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49:8-31.
43. Brenner H, Hakulinen T. Long-term cancer patient survival achieved by the end of the 20th century: most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer 2001; 85(3):367-371.
44. Boyle P, Autier P, Bartelink H, et al. European code against cancer and scientific justification: third version (2003). Ann Oncol 2003; 14(7):973-1005.
45. Green A, Battistutta D, Hart V, Leslie D, Weedon D, The Nambour Study Group. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. Am J Epidemiol 1996; 144:1034-1040.
46. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296(6614):13-17.
47. Coebergh JWW, Neumann HAM, Vrints LW, Van Der Heijden L, Meijer WJ, Verhagen-Teulings MT. Trends in the incidence of nonmelanoma skin cancer in the SE Netherlands 1975-1988: a registry-based study. Br J Dermatol 1991; 125:353-359.
48. Roberts DL. Incidence of nonmelanoma skin cancer in West Glamorgan, South Wales. Br J Dermatol 1990; 122(3):399-403.
49. Scotto J, Fears TR, Fraumeni JF. Incidence of Non-melanoma skin cancer in the United States. NCI NIH Publication, 1983:n.83-n.2433.
50. Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore cancer registry data 1968-1997. Br J Dermatol 2003; 148:1161-1166.
51. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and nonmelanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149:1200-1206.
52. Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among caucasians in four areas of the United States. Cancer 1974; 34:1333-1338.
53. Kaldor J, Shugg D, Young B, Dwyer T, Wang YG. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer 1993; 53:886-891.
54. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990; 46:356-361.
55. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001; 45: 528-536.
56. Miller DL, Weinstock MA. Non melanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30:774-778.
57. Gallagher RP, Ma B, McLean DI, et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin, 1973-87. J Am Acad Dermatol 1990; 23:413-421.
58. Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer 1993; 53:585-590.
59. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998; 78:587-593.
60. Osterlind A, Hou-Jensen K, Moller Jensen O. Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with nonmelanoma skin cancer. Br J Cancer 1988; 58:385-391.
61. Holme SA, Malinovszky K, Roberts DL. Changing trends in nonmelanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000; 143:1224-1229.
62. Omari AK, Khammash MR, Matalka I. Skin cancer trends in northern Jordan. Int J Dermatol 2004:1-5.
63. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999; 135:781-786.
64. Levi F, Francesci S, Te VC, Randimbison L, La Vecchia C. Trends of skin cancer in the Canton of Vaud, 1976-1992. Br J Cancer 1995; 72:1047-1053.
65. Plesko I, Severi G, Boyle P. Trends in the incidence of nonmelanoma skin cancer in Slovakia, 1978-1995. Neoplasma 2000; 47(3):137-142.
66. Revenga FA, Paricio JFR, Mar Vazquez MS, del VillarVS. Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in soria (north-eastern Spain) 1998-2000: a hospital-based survey. J Eur Acad Dermatol Venereol 2004; 18:137-141.
67. Ko CB, Walton S, Keczkes K, Bury HPR, Nicholson C. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130:269-272.
68. De Vries E, Louwman M, Bastiaens M, de Gruijl F, Coeabergh JW. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol 2004; 123:634-638.
69. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 8589:795-797.
70. Osterlind A, Hjalgrim H, Kulinsky B, Frentz G. Skin cancer as a cause of death in Denmark. Br J Dermatol 1991; 125:580-582.
71. Dunn JE, Levin EA, Linden G, Hartzfeld L. Skin cancer as a cause of death. Calif Med 1965; 102:361-363.
72. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48:425-429.
73. Diffey BL, Langtry JAA. Skin cancer incidence and the ageing population. Br J Dermatol 2005; 153(3):679.